ATE543509T1 - Material und verfahren zur förderung der reparatur von nervengewebe - Google Patents

Material und verfahren zur förderung der reparatur von nervengewebe

Info

Publication number
ATE543509T1
ATE543509T1 AT02763451T AT02763451T ATE543509T1 AT E543509 T1 ATE543509 T1 AT E543509T1 AT 02763451 T AT02763451 T AT 02763451T AT 02763451 T AT02763451 T AT 02763451T AT E543509 T1 ATE543509 T1 AT E543509T1
Authority
AT
Austria
Prior art keywords
methods
nerve
compositions
nerve tissue
subject invention
Prior art date
Application number
AT02763451T
Other languages
English (en)
Inventor
David Muir
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE543509T1 publication Critical patent/ATE543509T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02763451T 2001-08-13 2002-08-13 Material und verfahren zur förderung der reparatur von nervengewebe ATE543509T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31187001P 2001-08-13 2001-08-13
PCT/US2002/025922 WO2003015612A2 (en) 2001-08-13 2002-08-13 Materials and methods to promote repair of nerve tissue

Publications (1)

Publication Number Publication Date
ATE543509T1 true ATE543509T1 (de) 2012-02-15

Family

ID=23208862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763451T ATE543509T1 (de) 2001-08-13 2002-08-13 Material und verfahren zur förderung der reparatur von nervengewebe

Country Status (13)

Country Link
US (8) US7851447B2 (de)
EP (1) EP1425390B1 (de)
JP (1) JP4749667B2 (de)
KR (1) KR20040021697A (de)
CN (1) CN1553952A (de)
AT (1) ATE543509T1 (de)
BR (1) BR0211888A (de)
CA (1) CA2455827C (de)
ES (1) ES2378227T3 (de)
HU (1) HUP0500634A3 (de)
IL (1) IL160188A0 (de)
MX (1) MXPA04001334A (de)
WO (1) WO2003015612A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670179B1 (en) * 2001-08-01 2003-12-30 University Of Kentucky Research Foundation Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth
HUP0500634A3 (en) 2001-08-13 2006-03-28 Univ Florida Materials and methods to promote repair of nerve tissue
GB0205022D0 (en) * 2002-03-04 2002-04-17 Univ Cambridge Tech Materials and methods for the treatment of cns damage
EP1575548B1 (de) 2002-05-04 2011-03-09 Acorda Therapeutics, Inc. Zusammensetzungen und verfahren zur förderung des neuronalen wachstums
US7163545B2 (en) * 2002-07-29 2007-01-16 Mayo Foundation For Medical Education And Research Spinal cord surgical implant
DE60337009D1 (de) * 2002-08-15 2011-06-16 Acorda Therapeutics Inc Chimärisches protein
US7135027B2 (en) * 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
AU2004241088B2 (en) * 2003-05-16 2010-08-05 Acorda Therapeutics, Inc. Compositions and methods for the treatment of CNS injuries
US8906363B2 (en) * 2003-05-16 2014-12-09 Acorda Therapeutics, Inc. Fusion proteins for the treatment of CNS
EP1646353A4 (de) * 2003-05-16 2008-06-04 Acorda Therapeutics Inc Fusionsproteine zur behandlung des zns
US7959914B2 (en) * 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
EP1737476A4 (de) * 2004-01-30 2009-07-22 Univ Emory Materialien und verfahren zur förderung von nervenregeneration
WO2005112986A2 (en) * 2004-05-18 2005-12-01 Acorda Therapeutics, Inc. Purifying chondroitinase and stable formulations thereof
WO2005122734A2 (en) * 2004-06-14 2005-12-29 The Research Foundation Of State University Of New York Nanosphere/microsphere delivery system for the treatment of spinal cord injury
US20060041318A1 (en) * 2004-08-19 2006-02-23 Shannon Donald T Laminar skin-bone fixation transcutaneous implant and method for use thereof
US7485295B2 (en) 2005-09-26 2009-02-03 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
US7599774B2 (en) * 2006-03-10 2009-10-06 Gm Global Technology Operations, Inc. Method and system for adaptively compensating closed-loop front-wheel steering control
EP2042190A4 (de) * 2006-05-19 2012-05-30 Aichi Prefecture Mittel zur linderung von gehirnschäden
EP2079835B1 (de) 2006-10-10 2014-03-26 Acorda Therapeutics, Inc. Zusammensetzungen und verfahren zur verwendung von chondroitinase-abci-mutanten
WO2008149428A1 (ja) * 2007-06-05 2008-12-11 Glycoscience Laboratories, Inc. 自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤
WO2009124170A1 (en) * 2008-04-04 2009-10-08 The Cleveland Clinic Foundation Use of epineural sheath grafts for neural regeneration and protection
WO2009128076A2 (en) 2008-04-18 2009-10-22 Collplant Ltd. Methods of generating and using procollagen
US20110311521A1 (en) 2009-03-06 2011-12-22 Pico Caroni Novel therapy for anxiety
US8758374B2 (en) 2010-09-15 2014-06-24 University Of Utah Research Foundation Method for connecting nerves via a side-to-side epineurial window using artificial conduits
WO2012177238A1 (en) * 2011-06-21 2012-12-27 Tamara Tennison System and method of repairing of neural networks
WO2013066619A1 (en) 2011-10-17 2013-05-10 University Of Utah Research Foundation Methods and devices for connecting nerves
US10842494B2 (en) 2011-10-17 2020-11-24 University Of Utah Research Foundation Methods and devices for connecting nerves
EP2798057B1 (de) 2011-12-30 2018-08-22 Vivex Biomedical, Inc. Regenerative gewebematrix
CN102716470B (zh) * 2012-06-28 2015-02-04 中国人民解放军第三军医大学第三附属医院 一种治疗周围神经损伤的药物组合物
WO2016145452A1 (en) 2015-03-12 2016-09-15 Myoscience, Inc. Methods and systems for preventing neuroma formations
US11513039B2 (en) 2015-05-28 2022-11-29 Axogen Corporation Nerve culture system
US9690975B2 (en) * 2015-05-28 2017-06-27 Axogen Corporation Quantitative structural assay of a nerve graft
US11156595B2 (en) 2015-05-28 2021-10-26 Axogen Corporation Organotypic DRG-peripheral nerve culture system
CN105239137A (zh) * 2015-10-29 2016-01-13 无锡桥阳机械制造有限公司 一种电镀工艺
US10064938B2 (en) 2016-03-11 2018-09-04 University Of Wyoming Localized immunosuppression of allografts for peripheral nerve repair
AU2017375956C1 (en) * 2016-12-12 2023-12-14 The Regents Of The University Of California Biomimetic implants
WO2018127554A1 (en) * 2017-01-06 2018-07-12 Novahep Ab Methods of preparing bioengineered or bioprinted organ or tissue, and uses thereof
JPWO2019054407A1 (ja) * 2017-09-15 2020-10-29 東洋紡株式会社 神経保護材
US11623022B2 (en) 2017-11-15 2023-04-11 University of Pittsburgh—of the Commonwealth System of Higher Education Systems and methods for reconstruction of nerve defects
KR102888976B1 (ko) * 2018-04-12 2025-12-04 옥소젠 코포레이션 사전 제작 부착점을 가지는 조직 이식편
WO2020014889A1 (zh) * 2018-07-18 2020-01-23 中山大学附属第一医院 四肢主干神经的仿生修复体模型的建立方法
CN108992709B (zh) * 2018-07-27 2021-05-14 山东省眼科研究所 一种脱细胞神经基质材料及其制备方法和应用
US11376219B2 (en) 2018-07-30 2022-07-05 University Of Wyoming Localized immunosuppression of allografts for peripheral nerve repair
US20200054467A1 (en) * 2018-08-20 2020-02-20 Zakary Llamo-Cohen Method for establishing an electrically conductive artificial nerve
CN113056294A (zh) * 2018-11-15 2021-06-29 阿克松根股份公司 使用动物来源神经移植物的神经修复所用的材料及方法
US11147558B2 (en) * 2018-11-15 2021-10-19 Axogen Corporation Materials and methods for nerve repair with animal-sourced grafts
CN109893680B (zh) * 2019-03-07 2021-10-08 宁波光远致信生物科技有限公司 一种修复纤维膜、修复套接管及其制备方法和用途
WO2021138399A1 (en) 2019-12-30 2021-07-08 Renerva, Llc Extracellular matrix systems, devices, and methods of deployment
US11998661B2 (en) * 2020-10-22 2024-06-04 Axogen Corporation Fasciculated nerve grafts, methods of making the same, and methods of treatment using the same
WO2022256401A1 (en) * 2021-06-01 2022-12-08 Xenotherapeutics, Inc. Xenogeneic nerve transplants and methods
AU2022353834A1 (en) * 2021-09-30 2024-04-18 Renerva, Llc Nerve graft systems, devices, and methods
US20250295836A1 (en) * 2022-04-27 2025-09-25 Board Of Regents, The University Of Texas System Polyethylene glycol-fusion in nerve repair
CN115944784B (zh) * 2023-01-04 2024-12-03 南通大学 一种细胞化纤维支架及其制备方法和应用
CN116570770B (zh) * 2023-07-12 2023-11-07 天新福（北京）医疗器材股份有限公司 一种双层冻干管状物及其制备方法与应用
US20250124576A1 (en) * 2023-10-17 2025-04-17 Axogen Corporation Methods for analyzing a processed nerve graft

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US40112A (en) * 1863-09-29 Improvement in metallic cartridges
US77258A (en) * 1868-04-28 Improvement in weeding-hoe
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4696816A (en) * 1985-11-07 1987-09-29 Brown Mark D Method for treating intervertebral disc displacement with enzymes
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US4877029A (en) * 1987-03-30 1989-10-31 Brown University Research Foundation Semipermeable nerve guidance channels
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
WO1991006303A1 (en) 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
AU6734190A (en) 1989-10-31 1991-05-31 La Jolla Cancer Research Foundation Inhibitor of laminin neurite promoting activity
ZA912770B (en) 1990-04-16 1992-01-29 Bethesda Eye Inst Enzymatic disinsertion of vitreous body
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5231580A (en) 1991-04-01 1993-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Automated method and apparatus for determining characteristics of nerve fibers
US5496718A (en) 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
JP3419811B2 (ja) 1993-02-24 2003-06-23 マルハ株式会社 コンドロイチナーゼ遺伝子
CA2169191C (en) 1993-08-26 2008-01-15 Elizabeth A. Wang Neural regeneration using human bone morphogenetic proteins
US5916557A (en) * 1993-11-12 1999-06-29 The Trustees Of Columbia University In The City Of New York Methods of repairing connective tissues
EP0729976A1 (de) * 1993-11-19 1996-09-04 Chugai Seiyaku Kabushiki Kaisha Rekonstituierter humaner antikoerper gegen humane medulloblastomzellen
JPH10500843A (ja) * 1994-04-22 1998-01-27 アメリカン・サイアナミド・カンパニー コンドロイチナーゼｉおよびｉｉ、その製造法および用途
US6093563A (en) 1994-07-08 2000-07-25 Ibex Technologies R And D, Inc. Chondroitin lyase enzymes
US5997863A (en) 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes
US6214987B1 (en) * 1994-09-02 2001-04-10 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides
US6057137A (en) * 1994-10-06 2000-05-02 Regents Of The University Of Minnesota Tissue-equivalent rods containing aligned collagen fibrils and schwann cells
US5487756A (en) * 1994-12-23 1996-01-30 Simon Fraser University Implantable cuff having improved closure
ATE219146T1 (de) 1995-01-30 2002-06-15 Lunamed Ag Antitumorpräparate, die eine lipoteichonsäure aus streptococcus enthalten
US6033660A (en) * 1995-05-10 2000-03-07 Genentech, Inc. Method of treating a nervous system injury with cultured schwann cells
US5830468A (en) * 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US6231608B1 (en) * 1995-06-07 2001-05-15 Crosscart, Inc. Aldehyde and glycosidase-treated soft and bone tissue xenografts
JP3093974B2 (ja) 1995-06-27 2000-10-03 住友ベークライト株式会社 神経細胞用培養液、その製造方法及びこれを用いる神経細胞の培養方法
US6313265B1 (en) * 1995-07-24 2001-11-06 The Scripps Research Institute Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use
DE19530556C1 (de) 1995-07-28 1996-09-05 Will Prof Dr Minuth Verfahren zum Kultivieren von Zellen des menschlichen oder tierischen Körpers
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
SE9602879D0 (sv) * 1996-07-26 1996-07-26 Henrich Cheng Medical device
CA2285940A1 (en) * 1997-04-11 1998-10-22 K. Ramakrishnan Bhaskar Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
EP0875253B1 (de) 1997-05-02 2005-04-06 Seikagaku Corporation Chondroitinase enthaltende Zusammensetzungen
US6448076B2 (en) * 1998-09-15 2002-09-10 The Regents Of The University Of Michigan Method for chemically acellularizing a biological tissue sample
EP1119611B1 (de) * 1998-10-06 2006-10-18 Rush University Medical Center Zusammensetzung zur verwendung in der chemonukleolyse
US20030068815A1 (en) 1999-02-11 2003-04-10 Stone Kevin R. Sterilized xenograft tissue
US6267786B1 (en) 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
CA2414185A1 (en) 1999-11-17 2001-05-25 Ibex Technologies, Inc. Attenuation of tumor growth, metastasis and angiogenesis by use of chondroitin sulfate degrading enzymes
CA2393186A1 (en) 1999-12-02 2001-06-07 Ibex Technologies, Inc. Attenuation of fibroblast proliferation
CA2397562A1 (en) 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system
ATE374623T1 (de) 2000-07-28 2007-10-15 Dainippon Sumitomo Pharma Co Förderer der nervenregeneration die als aktiven bestandteil einen semaphorinhemmer enthalten
HUP0500634A3 (en) * 2001-08-13 2006-03-28 Univ Florida Materials and methods to promote repair of nerve tissue
EP1761550A2 (de) 2004-05-26 2007-03-14 California Institute of Technology Stimulatoren kleiner moleküle für nervenwachstum

Also Published As

Publication number Publication date
US6972168B2 (en) 2005-12-06
US7851447B2 (en) 2010-12-14
JP2005500375A (ja) 2005-01-06
HUP0500634A2 (hu) 2005-09-28
CN1553952A (zh) 2004-12-08
JP4749667B2 (ja) 2011-08-17
WO2003015612A3 (en) 2004-03-25
CA2455827A1 (en) 2003-02-27
US20030040112A1 (en) 2003-02-27
CA2455827C (en) 2015-06-09
US20110082482A1 (en) 2011-04-07
ES2378227T3 (es) 2012-04-10
US20030072749A1 (en) 2003-04-17
US8986733B2 (en) 2015-03-24
US20030077258A1 (en) 2003-04-24
EP1425390A4 (de) 2009-03-04
KR20040021697A (ko) 2004-03-10
US20040180434A1 (en) 2004-09-16
US20160339148A1 (en) 2016-11-24
IL160188A0 (en) 2004-07-25
WO2003015612A2 (en) 2003-02-27
US20080299536A1 (en) 2008-12-04
US7732200B2 (en) 2010-06-08
BR0211888A (pt) 2004-08-24
US9402868B2 (en) 2016-08-02
EP1425390A2 (de) 2004-06-09
MXPA04001334A (es) 2004-05-05
WO2003015612A9 (en) 2004-04-29
US10441681B2 (en) 2019-10-15
EP1425390B1 (de) 2012-02-01
HUP0500634A3 (en) 2006-03-28
US20130337549A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
ATE543509T1 (de) Material und verfahren zur förderung der reparatur von nervengewebe
BR0315645A (pt) Polipetìdeos de fusão de actrib e seus usos
ATE446776T1 (de) Zusammensetzung zur gefässbeschichtung
ATE306935T1 (de) Zusammensetzung zur förderung des wachstums von duralem oder meningealem gewebe enthaltend kollagen
SE9901973L (sv) Implantat för applicering i ben och förfarande och användning vid sådant implantat
DE60043271D1 (de) Methoden und Zusammensetzungen zur Heilung und Reparatur von Gelenkknorpeln
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
NZ527565A (en) Methods and devices for tissue repair
ATE402002T1 (de) Elektroverarbeitetes kollagen
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
DE60042027D1 (de) Biotechnische kollagenfibrillen
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
DE602004016008D1 (de) Biosynthetisches implantat und seine verwendung und verfahren zur reduzierung des risikos der bildung von bindegewebe nach der implantation
WO2006093860A3 (en) Method and composition for repairing heart tissue
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
WO1999016406A3 (en) Therapeutic method
WO2004004663A3 (en) Compositions and methods for ligament growth and repair
DE60326157D1 (de) Verfahren zur identifizierung von modulatoren der glucoseaufnahme
MY179011A (en) Tissue-engineered articular cartilage